No Data
No Data
Express News | Trevena Preclinical Reveals TRV045 Data Providing Insight Into Novel Mechanism Of Analgesic Effect In Chronic Neuropathic Pain Model And Demonstrating Statistically Significant Anti-Seizure Activity In Epilepsy Models
Express News | Trevena Shares Down 20% After Co Reports Preclinical Data for Its Experimental Drug
Tempest TPST Data; Trevena TRVN Preclinical Data
12 Health Care Stocks Moving In Thursday's Pre-Market Session
GainersTempest Therapeutics (NASDAQ:TPST) shares rose 32.8% to $3.79 during Thursday's pre-market session. The company's market cap stands at $84.0 million. Neurogene (NASDAQ:NGNE) shares rose 31.92%
Express News | Trevena Shares up 4.4% Premarket on Positive Data for Experimental Drug in Mouse Models
Express News | Trevena: Trv045 Shows Seizure Protection in Validated Preclinical Models
Lucky2828 : Look at how they short sell the shares. Just dump whenever there's a buyer.
102765799 : oh dear dropping more to the pits?